Jakobsson, H
196, 111511 10.1016/j.jphotobiol.2019.111511 [DOI] [PubMed] [Google Scholar] 123.Hu S., He W., Du X., Huang Y., Fu Y., Yang Y.et al
Oliveira-Marques, V., Marinho, H
however, specific markers are available to identify them.[31] Mesenchymal SCs (MSCs) are extensively studied cell types in regenerative medicine due to their immunomodulatory properties.[32] Studies have shown that MSC has the capacity to differentiate into osteocytes, adipocytes, myocytes and cells of chondrogenic lineage.[17] MSCs express markers that include CD73, CD90 and CD105 (endoglin) but not CD11b, CD14, CD19, CD34, CD45, CD79a and human leukocyte antigen Class II.[33] Hematopoietic SCs express two important hematopoietic markers, i.e., CD45 and CD34.[34] Certain markers have been used as pluripotent markers such as OCT4, NANOG and SOX2